January 16, 2009 - Royal Philips Electronics and Hansen Medical Inc. this week signed joint development and cooperation agreements to co-develop integrated products that may simplify complex cardiac procedures to diagnose and treat arrhythmias.
January 16, 2009 - St. Jude Medical Inc. today said results from the landmark FAME (Fractional flow reserve (FFR) vs. Angiography in Multivessel Evaluation) study, which demonstrate a statistically significant 30 percent difference in major adverse cardiac events (MACE) such as death, myocardial infarction and repeat revascularization, was published in the New England Journal and Medicine.
January 16, 2009 - St. Jude Medical Inc. said its ViewMate II Ultrasound System with the ViewFlex PLUS Intracardiac ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
January 16, 2009 – The FDA granted Fluke Biomedical U.S. Food and Drug 510(k) clearance for the Impulse 7010 ...
January 15, 2009 - Implantable cardioverter defibrillators (ICDs) may reduce the risk of death by 30 percent in older ...
January 15, 2009 - The six-month follow-up examination of a 64-year-old man enrolled in SECRITT I, a pilot study ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

Is an evolution of sorts happening within advanced visualization?
January 14, 2009 - According to Millennium Research Group's (MRG's) U.S. Markets for Electrophysiology (EP) Mapping and ...
January 14, 2009 - University of Ottawa Heart Institute (UOHI) researchers have successfully grown blood vessels in ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 14, 2009 - Society of Nuclear (SNM) will devote its annual Molecular Imaging Summit to introducing the new SNM ...
January 13, 2009 - Micell Technologies, a development-stage biomedical device company dedicated to developing innovative interventional cardiology systems, has obtained the rights to Maxcor's CE-marked Genius MAGIC Cobalt Chromium Coronary Stent System for the purpose of developing and marketing drug-eluting stents (DES) based on Micell's prop coating technology.
January 13, 2009 - Edwards Lifesciences Corp. said Jan. 9 the Patents Court in the United Kingdom upheld the validity of ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 13, 2009 - Michigan CardioVascular Institute (MCVI), a twenty-two location cardiovascular group practice based ...
January 13, 2009 -W.L. Gore and Associates today said it received CE Mark of its GORE VIABAHN Endoprosthesis with ...
January 13, 2009 - Cardima Inc. plans to showcase its atrial fibrillation treatment products and technologies at the ...